Tech Company Financing Transactions

Novadip Biosciences Funding Round

CR-CP Life Science Fund, private investors and InvestSud joined a $39.9 million Series B funding round for Novadip Biosciences. The round was announced on 11/3/2022.

Transaction Overview

Announced On
11/3/2022
Transaction Type
Venture Equity
Amount
$39,900,000
Round
Series B
Proceeds Purpose
The funding will accelerate the clinical development of two of Novadip's investigational adipose stem cell (ASC)-derived tissue regeneration products: NVD-X3, an allogeneic therapeutic that can provide accelerated, durable bone union in spinal fusion procedures and non-healing fractures, and

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Watson & Crick Hill, Rue Granbonpré 11,
Mont-Saint-Guibert, 1435
Belgium
Email Address
Overview
Novadip is transforming the lives of patients using its unique "3M3" tissue regeneration technology platform. Based on the scientific discoveries of Prof. Dr. Denis Dufrane, Novadip is a spin-off company from Université Catholique de Louvain (UCLouvain) and St. Luc University Hospital. The creation of Novadip was supported by the Louvain Technology Transfer Office (LTTO), Sopartec and VIVES II. Using our unique 3M3 tissue regeneration platform, which utilizes adipose-derived stem cells within a 3-dimensional extracellular matrix, to drive multiple product classes, Novadip's mission is to provide innovative solutions for patients with limited or no effective treatment options.
Profile
Novadip Biosciences LinkedIn Company Profile
Social Media
Novadip Biosciences Company Twitter Account
Company News
Novadip Biosciences News
Facebook
Novadip Biosciences on Facebook
YouTube
Novadip Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chairman
Eric Paques
  Eric Paques LinkedIn Profile  Eric Paques Twitter Account  Eric Paques News  Eric Paques on Facebook
Chief Executive Officer
Denis Dufrane
  Denis Dufrane LinkedIn Profile  Denis Dufrane Twitter Account  Denis Dufrane News  Denis Dufrane on Facebook
Chief Financial Officer
Virginie Cartage
  Virginie Cartage LinkedIn Profile  Virginie Cartage Twitter Account  Virginie Cartage News  Virginie Cartage on Facebook
Chief Technical Officer
Nicolas Theys
  Nicolas Theys LinkedIn Profile  Nicolas Theys Twitter Account  Nicolas Theys News  Nicolas Theys on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/3/2022: Alethea venture capital transaction
Next: 11/3/2022: Loop venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary